JACC: CardioOncology Video Case Presentation | Early Immune Checkpoint Inhibitor Cardiotoxicity

Published 2021-01-12

Recommendations

Similar videos

40:04

JACC: CardioOncology Video Case Presentation: Cardiotoxicity During HER2-Targeted Therapy
34:38

JACC: CardioOncology Virtual Case Presentation Series: Amyloidosis | Part One
17:34

Cardio oncology – Risk Prediction and Surveillance for Cardiotoxicity in Cancer Patients
36:21

JACC: CardioOncology Virtual Case Presentation Series: Amyloidosis | Part Two
10:24

Role of Cardioprotection in Cancer Therapy Cardiotoxicity | JACC: CardioOncology Author Discussion
30:23

Lecture looking ahead - Potential barriers to immune checkpoint inhibitors use in MIBC
1:02:01

Cardiotoxicity from Immunotherapy: Can Advanced Cardiac Imaging Meet the Challenge?
58:28

JACC: CardioOncology Virtual Journal Club | June 30, 2020
11:56

Radiation Therapy and Cardiovascular Disease | JACC: CardioOncology Author Discussion
1:02:05

Advanced Cardiac Imaging Among Patients with Cardiovascular Complications From Cancer Immunotherapy
55:09

Cardio-oncology: Chemotherapy-related left ventricular dysfunction
02:03

JACC Video | Clinical Outcomes Between BVP and LBBAP Among Patients Undergoing CRT
10:17

Understanding Tyrosine Kinase Toxicity | JACC: CardioOncology: GCOS 2019, Sao Paolo, Brazil
56:25

Dissecting Toxicities of Immune Checkpoint Inhibitors with Dr. Douglas Johnson, M.D., MSCI
15:45

Drs. Ky and Witteles Discuss the Amyloidosis Special Issue | JACC: CardioOncology
24:43

Dr. Javid Moslehi: Why cardiologists must care about cancer immunotherapy
59:13

Improving the Management of Cardiac Immune-Related Adverse Events in Patients With Cancer
07:39

How should we deal with cardiotoxicity caused by immunotherapy?
57:02

Cardio-Oncology Impatient Consults
More results